Karen May has extensive experience in the pharmaceutical industry, holding prominent positions in program and clinical operations. From October 2020 to April 2021, Karen May served as Senior Director of Program Management at AstraZeneca. Prior to this, from July 1995 to September 2020, Karen May was the Head of Clinical Operations for Established Tumors at Bristol Myers Squibb. Currently, Karen May is the Executive Director of Clinical Operations at AstraZeneca, a role assumed in April 2021.
This person is not in the org chart
This person is not in any teams
This person is not in any offices